Sermorelin 6 mg and Sermorelin 6 mg/GHRP-2 Injection recalled over sterility concerns
- Recall date
- July 19, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Talon Compounding Pharmacy recalls Sermorelin 6 mg and Sermorelin 6 mg/GHRP-2 Injection, 12 mg, 10 ml depyrogenated vials, Rx Only, Compounded by Talon Co…
- Recall number
- D-1463-2016
- FDA classification
- Class II
- Brand / firm
- Talon Compounding Pharmacy
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sermorelin 6 mg and Sermorelin 6 mg/GHRP-2 Injection, 12 mg, 10 ml depyrogenated vials, Rx Only, Compounded by Talon Compounding Pharmacy, San Antonio, TX 78247
Get recall alerts
Free email alert whenever Talon Compounding Pharmacy has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Talon Compounding Pharmacy